Centogene Net Income Over Time
| CNTGF Stock | 0.11 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Centogene Performance and Centogene Correlation. Centogene | Build AI portfolio with Centogene Stock |
Can Life Sciences Tools & Services industry sustain growth momentum? Does Centogene have expansion opportunities? Factors like these will boost the valuation of Centogene. Projected growth potential of Centogene fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Centogene demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.47) | Revenue Per Share 1.723 | Quarterly Revenue Growth (0.08) | Return On Assets (0.27) |
Investors evaluate Centogene NV using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Centogene's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Centogene's market price to deviate significantly from intrinsic value.
It's important to distinguish between Centogene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Centogene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Centogene's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income Analysis
Compare Centogene NV and related stocks such as Mettler Toledo Inter, Alcon AG, and ResMed Inc Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MTD | (65.9 M) | 269.5 M | 290.8 M | 306.1 M | 338.2 M | 352.8 M | 384.4 M | 376 M | 512.6 M | 561.1 M | 602.7 M | 769 M | 872.5 M | 788.8 M | 863.1 M | 869.2 M | 912.7 M |
| ALC | 931 M | 296.3 M | 296.3 M | 296.3 M | 296.3 M | 296.3 M | (170 M) | 256 M | (227 M) | (656 M) | (531 M) | 376 M | 335 M | 974 M | 1 B | 916.2 M | 962 M |
| RMD | 800 K | 254.8 M | 307.1 M | 345.3 M | 352.9 M | 352.4 M | 342.3 M | 315.6 M | 404.6 M | 621.7 M | 474.5 M | 779.4 M | 897.6 M | 1 B | 1.4 B | 1.6 B | 1.7 B |
| HLN | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 655 M | 1.1 B | 1.4 B | 1.1 B | 1 B | 1.4 B | 1.7 B | 1.2 B |
| CAH | 6 M | 1.1 B | 334 M | 1.2 B | 1.2 B | 1.4 B | 1.3 B | 256 M | 1.4 B | (3.7 B) | 611 M | (938 M) | 330 M | 852 M | 1.6 B | 1.8 B | 1.9 B |
| BDX | 88 M | 1.2 B | 1.3 B | 1.2 B | 695 M | 976 M | 1.1 B | 311 M | 1.2 B | 874 M | 2.1 B | 1.8 B | 1.5 B | 1.7 B | 1.7 B | 1.9 B | 2 B |
| INSM | (7.8 M) | (59.7 M) | (41.4 M) | (56.1 M) | (79.2 M) | (118.2 M) | (176.3 M) | (192.6 M) | (324.3 M) | (254.3 M) | (294.1 M) | (434.7 M) | (481.5 M) | (749.6 M) | (913.8 M) | (822.4 M) | (781.3 M) |
| EW | 82 M | 236.7 M | 293.2 M | 391.7 M | 811.1 M | 494.9 M | 569.5 M | 622.1 M | 722.2 M | 1 B | 823.4 M | 1.5 B | 1.5 B | 1.4 B | 4.2 B | 1.1 B | 673.1 M |
Centogene NV and related stocks such as Mettler Toledo Inter, Alcon AG, and ResMed Inc Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Centogene NV financial statement analysis. It represents the amount of money remaining after all of Centogene NV operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Centogene NV | CNTGF |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Am Strande 7, |
| Exchange | NASDAQ Exchange |
null 0.11
Check out Centogene Performance and Centogene Correlation. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Centogene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.